121 related articles for article (PubMed ID: 4025038)
1. Long-acting therapy of schizophrenia.
Rapisarda V; Bonomo V; Parisi R
Adv Biochem Psychopharmacol; 1985; 40():25-8. PubMed ID: 4025038
[No Abstract] [Full Text] [Related]
2. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
Roose K
Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
[TBL] [Abstract][Full Text] [Related]
3. Once weekly pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
McCreadie R; Mackie M; Morrison D; Kidd J
Br J Psychiatry; 1982 Mar; 140():280-6. PubMed ID: 7093596
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
Chouinard G; Annable L; Campbell W; Boisvert D; Bradwejn J
Psychopharmacol Bull; 1984; 20(1):108-9. PubMed ID: 6371871
[No Abstract] [Full Text] [Related]
5. Factors determining patient tenure on a 3-year double-blind investigation of pimozide versus fluphenazine HCl.
Abuzzahab FS; Zimmermann RL
Adv Biochem Psychopharmacol; 1980; 24():547-50. PubMed ID: 7405675
[No Abstract] [Full Text] [Related]
6. [Significance and advantages of Orap in the ambulatory care of schizophrenic psychoses].
König L; Lange E
Psychiatr Neurol Med Psychol (Leipz); 1976 Feb; 28(2):106-13. PubMed ID: 940884
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the incidence of tardive dyskinesias in 3 groups of patients treated with different neuroleptics].
Barcia D; Pozo P; Ruiz ME; Forcadell F; Morcillo L; Soria JM; Carrasco E
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1987; 15(1):25-8. PubMed ID: 3577874
[No Abstract] [Full Text] [Related]
8. Neuroleptic malignant syndrome: successful treatment with dantrolene and bromocriptine.
Granato JE; Stern BJ; Ringel A; Karim AH; Krumholz A; Coyle J; Adler S
Ann Neurol; 1983 Jul; 14(1):89-90. PubMed ID: 6614876
[TBL] [Abstract][Full Text] [Related]
9. Evaluations of social functioning in a 3-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia [proceedings].
Abuzzahab FS
Psychopharmacol Bull; 1977 Jan; 13(1):71-3. PubMed ID: 319477
[No Abstract] [Full Text] [Related]
10. Intermittent pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
McCreadie RG; Dingwall JM; Wiles DH; Heykants JJ
Br J Psychiatry; 1980 Dec; 137():510-7. PubMed ID: 7011468
[TBL] [Abstract][Full Text] [Related]
11. Maintenance treatment of schizophrenia with long-acting fluphenazine.
Niturad A; Ciurezu T; Cucu I
Act Nerv Super (Praha); 1974 Aug; 16(3):167. PubMed ID: 4154028
[No Abstract] [Full Text] [Related]
12. Clinical experience with fluphenazine decanoate in the treatment of patients with long-standing chronic schizophrenia.
Christodoulidis H; Frangos H
Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):193-8. PubMed ID: 809234
[No Abstract] [Full Text] [Related]
13. A three-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia.
Abuzzahab FS; Zimmermann RL
Psychopharmacol Bull; 1976 Apr; 12(2):26-7. PubMed ID: 769023
[No Abstract] [Full Text] [Related]
14. [Characteristics of the therapeutic action fluphenzaine decanoate (moditen-depot) in schizophrenia].
Tsutsul'kovskaia MIa; Minsker EI; Panteleeva GP; Mazurskii MB; Pekunova LG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(5):753-8. PubMed ID: 4718619
[No Abstract] [Full Text] [Related]
15. A controlled comparison of haloperidol and fluphenazine in chronic treatment-resistant schizophrenics.
Hall WB; Vestre ND; Schiele BC; Zimmermann R
Dis Nerv Syst; 1968 Jun; 29(6):405-8. PubMed ID: 4877748
[No Abstract] [Full Text] [Related]
16. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
[TBL] [Abstract][Full Text] [Related]
17. [Clinical observation on the effect of domestic fluphenazine decanoate in the treatment of schizophrenia---report of 431 cases (author's transl)].
Zhang YF
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Aug; 14(3):182-5. PubMed ID: 7333179
[No Abstract] [Full Text] [Related]
18. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
[TBL] [Abstract][Full Text] [Related]
19. Use of the Social Behaviour Assessment Schedule (SBAS) in a trial of maintenance antipsychotic therapy in schizophrenic outpatients: pimozide versus fluphenazine.
Barnes TR; Milavic G; Curson DA; Platt SD
Soc Psychiatry; 1983; 18(4):193-9. PubMed ID: 6356386
[No Abstract] [Full Text] [Related]
20. A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia.
Falloon I; Watt DC; Shepherd M
Psychol Med; 1978 Feb; 8(1):59-70. PubMed ID: 345313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
